vimarsana.com

Page 6 - தேசிய மருந்துகள் ப்ரைஸிஂக் அதிகாரம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Centre To Ramp Up Remdesivir Production To 74 Lakh Units Per Month From May

Centre To Ramp Up Remdesivir Production To 74 Lakh Units Per Month From May Centre To Ramp Up Remdesivir Production To 74 Lakh Units Per Month From May The home ministry has asked the states and Union territories to ensure seamless supply and transport of Remdesivir, used for the treatment of COVID-19. The supply of Remdesivir injection and imported drug Toclizumab is under severe constraint. (File) New Delhi: The production of life-saving Remdesivir injection used for the treatment of COVID-19 patients and is currently in scarcity in the country, will be augmented to 74 lakh units by next month from 38.80 lakh units now, the home ministry said.

AP Govt Caps Price Of Remdesivir Injection

India Coronavirus Dispatch: Govt assessing stock of antiviral remdesivir

Nearly 97,000 fresh cases reported India reported 96,982 fresh coronavirus infections on Tuesday, taking the cumulative caseload to 1,26,86,049, according to a report in the Scroll. The country saw 446 deaths due to the pandemic, taking the death toll to 1,65,547, according to central health ministry data. The active caseload is at 7,88,223, while the total recoveries have surged to 1,17,32,279. As many as 83.1 million shots have been administered since the nationwide inoculation programme kicked off on January 16. Of these, 43,00,966 were given on Monday. Read more here Centre assessing stock of remdesivir amid Covid surge Amid a surge in Covid-19 cases, the central government has begun to assess the availability of remdesivir, an antiviral drug, a report in ThePrint said. Remdesivir is a highly sought-after experimental drug to treat Covid-19 patients. The Department of Pharmaceuticals (DoP) has kicked off the drive to check available stocks in states which are reporting high

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.